Post-Doctoral Researchers.

Alice di Pasquale

Alice worked as a post-doctoral researcher in the group, and left in May 2023 to pursue further post-doctoral research at the University of Edinburgh

Saleta Vazquez-RodriguezSaleta worked as a Marie Curie post-doctoral research fellow from 2015-2020. She returned to her native Galicia to pursue and independent research career.

Saleta Vazquez-Rodriguez

Saleta worked as a Marie Curie post-doctoral research fellow from 2015-2020. She returned to her native Galicia to pursue an independent research career.

Stephane de CescoStephane worked as a post-doctoral researcher in the group from 2016-2020. He moved back to Belgium to take up a position at Confo Therapeutics.

Stephane de Cesco

Stephane worked as a post-doctoral researcher in the group from 2016-2020. He moved back to Belgium to take up a position at Confo Therapeutics.

Mark McLaughlinMark worked in the group as a post-doctoral researcher from 2016-2017. He left the group to take up an independent research position at Manchester Metropolitan University:https://mclaughlinresearchgroup.com/

Mark McLaughlin

Mark worked in the group as a post-doctoral researcher from 2016-2017. He left the group to take up an independent research position at Manchester Metropolitan University:

https://mclaughlinresearchgroup.com/

Kathryn PughKathryn worked as a post-doctoral researcher in the group from 2014-2015. She switched codes to work with the group of Kilian Huber at SGC Oxford on proteomic analysis of drug action.

Kathryn Pugh

Kathryn worked as a post-doctoral researcher in the group from 2014-2015. She switched codes to work with the group of Kilian Huber at SGC Oxford on proteomic analysis of drug action.

Andrew Thompson

Andrew worked as a post-doctoral researcher in the group between 2019-2022. Andrew left in September 2022 to take up a position in Melbourne, Australia

Carmen Jimenez AntunezCarmen worked as a post-doctoral researcher in the group from 2018-2020. She moved to London to take up a position at the ICR.

Carmen Jimenez Antunez

Carmen worked as a post-doctoral researcher in the group from 2018-2020. She moved to London to take up a position at the Institue for Cancer Research.

Raina SeupelRaina worked as a post-doctoral researcher in the group from 2018-2020. She then took up a position at Merck back in her native Germany.

Raina Seupel

Raina worked as a post-doctoral researcher in the group from 2018-2020. She then took up a position at Merck back in her native Germany.

Vinnie FaganVinnie worked as a post-doctoral researcher in the group from 2016-2019. He moved back to his native Ireland to begin a family with his wife Sarah.

Vinnie Fagan

Vinnie worked as a post-doctoral researcher in the group from 2016-2019. He moved back to his native Ireland to begin a family with his wife Sarah.

Rob Quinlan

Rob took his DPhil in the group between 2017-2022, and stayed on as a post-doctoral researcher throughout 2022. He left in December 2022 to take up a position at the Francis Crick Institute, London.

Tammas Szommer

Tammas was a post-doctoral researcher in the group, switching to the group of Brian Marsden at the CMD.

Anna CederbalkAnna worked as a post-doctoral researcher in the group from 2018-2020, before taking up a position at MoA Technology.

Anna Cederbalk

Anna worked as a post-doctoral researcher in the group from 2018-2020, before taking up a position at MoA Technology.

Gian-Filippo RudaFilippo worked as a post-doctoral researcher in the group from 2014-2020. He has since taken up a position as a Principal Scientist at Evotec.

Gian-Filippo Ruda

Filippo worked as a post-doctoral researcher in the group from 2014-2020. He has since taken up a position as a Principal Scientist at Evotec.

Dr Stephen Wren
Dr Josh Almond-Thynne
Dr Melissa D'Ascenzio
Dr Andrea Nuzzi
Dr. Aicha Boudhar
Dr. Alessio De Simone
Dr. Onur Atasoylu (Visiting Fellow)

Doctoral Students.

Loane Serrano

Miranda WrightMiranda completed her DPhil in August 2018 on the design of covalent inhibitors of KDM5. She recently began working at Vertex Pharmaceuticals.

Miranda Wright

Miranda completed her DPhil in August 2018 on the design of covalent inhibitors of KDM5. She recently began working at Vertex Pharmaceuticals.

Moses MoustakimMoses completed his DPhil in July 2018 on the development of small molecule epigenetic modulators. He is currently working for C4 Therapeutics in Boston.

Moses Moustakim

Moses completed his DPhil in July 2018 on the development of small molecule epigenetic modulators. He is currently working for C4 Therapeutics in Boston.

Janine Gray

Milan Fowkes

Elisabeth Rothweiler

Mira completed her DPhil in 2024 on investigating approaches for targeted protein degradation and ligand-based screening. She continues working as a post-doctoral researcher in the ARUK-ODDI.

Oakley Cox
Finn Wolfreys
Phil Gerken
David Bowkett
Duncan Hay
Yining Yang

Visiting Students and Research Assistants.

Nanki Singh

Nanki Singh

Ewa Wieczorek

Ewa Wieczorek

Maite Gomez Carvajal

Maite Gomez Carvajal

Mary Wilson (SBM CDT)

Mary Wilson (SBM CDT)

Aidan Kerckhoffs (SBM CDT)

Aidan Kerckhoffs (SBM CDT)

Adam Smith

Adam worked as a research assistant with the ARUK-ODDI from 2022-2024. He left in 2024 to pursue his PhD at the University of Edinburgh.

Holly Parsons (SBM CDT)
Leonardo Palaferri
Roberta Mazzone
Benoit Darlot (SBM CDT)
Holly Bunce (SBM CDT)
Hannah Kiely-Collins
Irene Sechi
Cynthia Melami
Mattias Basle
Stephane Duflocq 
Alexander Reim 

Part II Students.

Will Griffith

Beno Wiltshire

Naomi Costello

Dan Aspiazu

Tom Dyer